HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-144 Cr | ₹-27 Cr | ₹-7.68 Cr | ₹-5.56 Cr | ₹-97 Cr |
What is the latest Cash Flow from Financing Activities ratio of HIKAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-144 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-7.68 Cr |
| Mar2022 | ₹-5.56 Cr |
| Mar2021 | ₹-97 Cr |
How is Cash Flow from Financing Activities of HIKAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-144 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-7.68 Cr | Negative | |
| Mar2022 | ₹-5.56 Cr | Negative | |
| Mar2021 | ₹-97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,213.9 Cr | -4.1% | -19.6% | -46.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.1% |
-19.6% |
-46.3% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses